Friday, 23 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

MOPOLI Stock Bearish By 9% So Far Today

Loading stream...

(VIANEWS) - Shares of MOPOLI (BEL 20: MOP.BR) dropped 9.09% to €240.00 at 14:22 EST on Thursday, after five successive sessions in a row of losses. BEL 20 is rising 0.42% to €3,590.13, after four sequential sessions in a row of gains. This seems, at the moment, a somewhat bullish trend exchanging session today.

About MOPOLI

Palmboomen Cultuur Maatschappij Mopoli (Palmeraies De Mopoli) N.V. invests in tropical agro industry projects in Belgium. The company was incorporated in 1912 and is headquartered in Brussels, Belgium. Palmboomen Cultuur Maatschappij Mopoli (Palmeraies De Mopoli) N.V. is a subsidiary of Geselfina SA.

Earnings Per Share

As for profitability, MOPOLI has a trailing twelve months EPS of €3.56.

PE Ratio

MOPOLI has a trailing twelve months price to earnings ratio of 67.42. Meaning, the purchaser of the share is investing €67.42 for every euro of annual earnings.

More news about MOPOLI (MOP.BR).

Categories

stockMarket

Tags

MOP.BRStock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStockMOPOLI
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com
MOPOLI Stock Bearish By 9% So Far Today | ViaNews EU